Loading patent…
AssigneeElan Corporation, plc
InventorsEdward J. Geoghegan, Seamus Mulligan, Donald E. Panoz
Estimating the term…
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a pharmaceutically acceptable film-forming, water insoluble synthetic polymer and a minor proportion of a pharmaceutically acceptable film-forming, water soluble synthetic polymer. The number of layers in the membrane and the ratio of the water soluble to water insoluble polymer being effective to permit release of the diltiazem from the pellet at a rate allowing controlled absorption thereof over a twenty four hour period following oral administration.
A process for the production of a diltiazem pellet formulation for oral administration comprising:
Dependencies are inferred from the claim text.